Recruiting Pediatric Antibiotic Dosing in Extracorporal Membrane Oxygenation (PADECMO) NCT06426836 Conditions Amikacin, Amoxicillin-clavulanate, Cefazolin, +6 more Locations Queen Fabiola Children's University Hospital — Brussels, Brussels Capital, Belgium University Hospital — Ghent, Belgium Universitair hospital — Leuven, Belgium View Trial Details
Recruiting Antibiotic Dosing in Pediatric Intensive Care NCT02456974 Conditions Amikacin, Amoxicillin-clavulanate, Ciprofloxacin, +5 more Locations Ghent University Hospital, Hospital Pharmacy — Ghent, Belgium View Trial Details
Not Yet Recruiting Precision Dosing of Beta-lactam Antibiotics in Critically Ill Children NCT06929702 Conditions Amoxicillin-clavulanate, Meropenem, Piperacillin-tazobactam Locations Ghent University Hospital — Ghent, Belgium View Trial Details
Completed Empirical Meropenem Dosing in Critically Ill Patients: Early Assessment of Plasma Exposure and Minimum Inhibitory Concentration Targets NCT07681544 Conditions Critical Illness, Critically Ill, Disease Attributes, +5 more Locations Hospital Italiano de Buenos Aires — Buenos Aires, Argentina View Trial Details
Completed Pharmacokinetics of Intraperitoneal and Intravenous Meropenem, Ampicillin, Aztreonam and Ciprofloxacin in Automated Peritoneal Dialysis Patients Without Peritonitis NCT07113587 Conditions Ampicillin, Aztreonam, Ciprofloxacin, +8 more Locations UK St. Pölten — Sankt Pölten, Austria View Trial Details
Completed Pharmacokinetics of Meropenem and Aztreonam After Intraperitoneal Administration Via Cycler-therapy in APD Patients Without Peritonitis NCT07113574 Conditions Anti-bacterial Agents, Antibacterial Agents, Aztreonam, +25 more Locations UK St. Pölten — Sankt Pölten, Austria View Trial Details
Completed The OPTIMAL TDM Study: Determining Optimal Beta-lactam Plasma Concentrations Through Therapeutic Drug Monitoring NCT03790631 Conditions Amoxicillin, Beta-lactam Antibiotics, Cefepime, +8 more Locations Geneva University Hospitals — Geneva, Canton of Geneva, Switzerland View Trial Details
